OptimUM-01 drug interaction cocktail substudy: CYP3A4/5 and P-gp inhibitors and CYP3A4/5 inducers prohibited before dosing
“Moderate and strong inhibitors of CYP2A4/5 or P-gp are prohibited within 7 days, or within 5 half-lives, whichever is longer, of Cycle 1 Day -1.” (opens the source at this quote in a new tab)
“Intake of strong or moderate inducers of CYP3A4/5, CYP2B6, CYP2C9, CYP2C19, or OAT3 is prohibited during 15 days, or 5 half-lives, whichever is longer, prior to Cycle 1 Day -1.” (opens the source at this quote in a new tab)
“Intake of vitamin supplements containing Vitamin B6 (pyridoxine), grapefruit/grapefruit juice, or Seville orange juice within 7 days prior to Cycle 1 Day -1.” (opens the source at this quote in a new tab)
Clinical drug interaction studies with darovasertib as the affected drug
No evidence found.
Crizotinib label: strong and moderate CYP3A inhibitors and grapefruit
Crizotinib label: strong CYP3A inducers
Crizotinib label: gastric acid reducing agents and P-glycoprotein